Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michele Jara, Thomas Aquilina, Peter Aupperle & Adrian L Rabinowicz. (2015) Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States. Drug, Healthcare and Patient Safety 7, pages 169-174.
Read now
Read now
Articles from other publishers (6)
Andrea M. Sartori, Bárbara Padilla-Fernández, Lisette ‘t Hoen, Bertil F.M. Blok, David M. Castro-Díaz, Giulio Del Popolo, Stefania Musco, Rizwan Hamid, Hazel Ecclestone, Jan Groen, Gilles Karsenty, Veronique Phé, Thomas M. Kessler & Jürgen Pannek. (2022) Definitions of Urinary Tract Infection Used in Interventional Studies Involving Neurourological Patients—A Systematic Review. European Urology Focus 8:5, pages 1386-1398.
Crossref
Crossref
C. Donzé, C. Papeix, C. Lebrun-Frenay, C. Donzé, C. Papeix, C. Lebrun-Frénay, N. Collongues, M. de Seze, A. Dinh, A. Even, C. Scheiber-Nogueira, C. Bensa, B. Bourre, C. Carra-Dallière, J. Ciron, M. Cohen, A.M. Guennoc, C. Louapre, F. Lebreton, L. Michel, E. Maillart, B. Audoin, X. Ayrignac, P. Bernady, B. Brochet, P. Clavelou, R. Colamarino, A. Declemy, J. de Seze, N. Derache, J.-M. Faucheux, O. Heinzlef, P. Labauge, D. Laplaud, E. Lepage, E. Leray, L. Magy, G. Mathey, C. Mekies, V. Mondain, E. Planque, J. Pelletier, S. Pittion, B. Stankhof, P. Tournaire, E. Thouvenot, S. Vukusic, S. Wiertlevski, H. Zephir, H. Alchaar, G. Androdias, M. Benazet, D. Bensmail, D. Biotti, A. Blanchard-Dauphin, M. Bonnan, C. Boutière, P. Branger, S. Bresch, J.-P. Bru, J.-P. Camdessanché, E. Castel Canal, M. Coustans, O. Casez, B. Castan, A. Creange, E. Creisson, T. De Broucker, R. Depaz, X. Douay, C. Dulau, F. Durand-Dubief, O. Fagniez, M. Faucher, A. Floch, M. Fournier, A. Fromont, P. Gallien, X. Gamé, D. Gault, A. Gayou, M. Giroux, O. Gout, J. Grimaud, P. Hautecoeur, A. Kerbrat, L. Kremer, A. Kwiatkowski, C. Labeyrie, S. Lachaud, C. Lanctin-Garcia, L. Lanotte, E. Manchon, A. Maurousset, L. Michel, A.-M. Milor, X. Moisset, A. Mont-Cuquet, T. Moreau, J.-C. Ouallet, I. Patry, D. Peaureaux, M.-C. Pouget, V. Pourcher Martinez, C. Radot, A. Ruet, C. Saint-Val, A. Salmon, F. Taithe, P. Tatevin, M. Vaillant, J.-P. Stahl, F. Vuoto & C. Zaenker. (2020) Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society. Revue Neurologique 176:10, pages 804-822.
Crossref
Crossref
Washigton Luiz Gomes de Medeiros Junior, Caio Cesar Demore, Larissa Peres Mazaro, Matheus Fellipe Nascimento de Souza, Laura Fiuza Parolin, Luiz Henrique Melo, Claudio Rogerio Werka Junior & Marcus Vinicius Magno Gonçalves. (2020) Urinary tract infection in patients with multiple sclerosis: An overview. Multiple Sclerosis and Related Disorders 46, pages 102462.
Crossref
Crossref
Jeremy Hobart, Tjalf Ziemssen, Peter Feys, Michael Linnebank, Andrew D. Goodman, Rachel Farrell, Raymond Hupperts, Andrew R. Blight, Veronica Englishby, Manjit McNeill, Ih Chang, Gabriel Lima & Jacob Elkins. (2018) Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine. CNS Drugs 33:1, pages 61-79.
Crossref
Crossref
Magaly Lecat, Pierre Decavel, Eloi Magnin, Brigitte Lucas, Vincent Gremeaux & Yoshimasa Sagawa. (2017) Multiple Sclerosis and Clinical Gait Analysis before and after Fampridine: A Systematic Review. European Neurology 78:5-6, pages 272-286.
Crossref
Crossref
Björn Zörner, Linard Filli, Katja Reuter, Sandra Kapitza, Lilla Lörincz, Tabea Sutter, David Weller, Melinda Farkas, Christopher S Easthope, Adam Czaplinski, Michael Weller & Michael Linnebank. (2016) Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern. Multiple Sclerosis Journal 22:11, pages 1463-1475.
Crossref
Crossref